Skip to main content
. 2020 Apr 14;19(5):2053–2070. doi: 10.1021/acs.jproteome.9b00868

Figure 5.

Figure 5

Detailed heatmap representations depicting Mtb-associated amino acid and peptide abundance changes during disease progression. (A) Proteinogenic amino acid abundances. (B) Oligopeptide abundances annotated in the study. Note that oligopeptide annotations are indicative, since CE-TOF/MS cannot determine the amino acid sequence. A gradual increase in the levels of the majority of metabolites grouped in this section occurs with the disease progression.